[{"Assets_0_FY_USD":1038634000.0,"CIK":"1737287","CommonStockDividendsPerShareDeclared_4_FY_USD":0.0,"CommonStockSharesConverted_0_FY_shares":142623065.0,"CommonStockSharesOutstanding_0_FY_shares":142623065.0,"Country":"United States","EarningsPerShareBasic_4_FY_USD":-1.89,"EarningsPerShareDiluted_4_FY_USD":-1.89,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-184812000.0,"NetIncomeLossConverted_16_FY_USD":-903300000.0,"NetIncomeLossConverted_4_FY_USD":-257005000.0,"OfficialName":"Allogene Therapeutics Inc. Common Stock","RevenuesConverted_4_FY_USD":38489000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_FY_USD":916406000.0,"Ticker":"ALLO","WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":135820386.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":135820386.0,"filed":"20220223","footnote":"nan","form":"10-K","fp":"FY","fy":"2021.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20211231","qtrs":"0","uom":"USD"}]